Q0112 HCPCS Level II code: All potassium hydroxide (koh) preparations
Q0112 is the HCPCS code for “All potassium hydroxide (koh) preparations” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q0112All potassium hydroxide (koh) preparations
Short description: Potassium hydroxide preps
HCPCS · United States
Medicare details
The indicators CMS publishes with Q0112 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Clinical lab fee schedule – Price subject to national limitation amount
- Type of service
- Diagnostic laboratory
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Lab certification
- Mycology
- Added
- Jan 1, 1994
Where Q0112 sits
- 1Q codesTemporary codes
- 2Active code Q0112All potassium hydroxide (koh) preparations
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q0112 mean?
Q0112 is the HCPCS code for “All potassium hydroxide (koh) preparations” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q0112?
CMS lists Q0112’s Medicare coverage as “Carrier judgment” and its pricing as “Clinical lab fee schedule – Price subject to national limitation amount”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q0112
All Q codesQ0083Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visitQ0084Chemotherapy administration by infusion technique only, per visitQ0085Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visitQ0091Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratoryQ0092Set-up portable x-ray equipmentQ0111Wet mounts, including preparations of vaginal, cervical or skin specimensQ0113Pinworm examinationsQ0114Fern testQ0115Post-coital direct, qualitative examinations of vaginal or cervical mucousQ0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)Q0139Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gram